Skip to main content

INCYTE CORP

For the period ended Mar 31, 2025. Filed Apr 29, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 29, 2025

INCY$120.30-1.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except number of shares and par value)

March 31,2025December 31,2024*
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents$1,941,722$1,687,829
Marketable securities—available-for-sale (amortized cost $465,659 and $469,917 as of March 31, 2025 and December 31, 2024, respectively; allowance for credit losses $0 as of March 31, 2025 and December 31, 2024)466,936470,263
Accounts receivable823,134853,154
Inventory63,97558,872
Prepaid expenses and other current assets211,654168,912
Total current assets3,507,4213,239,030
Restricted cash1,6651,622
Long term equity investments17,46318,814
Inventory365,311348,327
Property and equipment, net765,359763,411
Finance lease right-of-use assets, net29,89230,803
Other intangible assets, net107,611113,803
Goodwill155,593155,593
Deferred income tax asset768,899762,071
Other assets, net30,15110,848
Total assets$5,749,365$5,444,322
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$195,537$197,465
Accrued compensation102,820188,677
Accrued and other current liabilities1,375,7381,212,048
Finance lease liabilities4,4784,419
Acquisition-related contingent consideration41,71739,238
Total current liabilities1,720,2901,641,847
Acquisition-related contingent consideration153,283153,762
Finance lease liabilities32,64333,542
Other liabilities175,586167,543
Total liabilities2,081,8021,996,694
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; none issued or outstanding——
Common stock, $0.001 par value; 400,000,000 shares authorized; 193,783,446 and 193,434,305 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively193193
Additional paid-in capital4,588,2864,533,437
Accumulated other comprehensive loss(6,238)(13,121)
Accumulated deficit(914,678)(1,072,881)
Total stockholders’ equity3,667,5633,447,628
Total liabilities and stockholders’ equity$5,749,365$5,444,322

*The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.